Aditxt Inc. (ADTX) - Total Liabilities
Based on the latest financial reports, Aditxt Inc. (ADTX) has total liabilities worth $20.66 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore ADTX cash flow metrics to assess how effectively this company generates cash.
Aditxt Inc. - Total Liabilities Trend (2017–2024)
This chart illustrates how Aditxt Inc. 's total liabilities have evolved over time, based on quarterly financial data. See Aditxt Inc. book value and equity for net asset value and shareholders' equity analysis.
Aditxt Inc. Competitors by Total Liabilities
The table below lists competitors of Aditxt Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Nuformix plc
LSE:NFX
|
UK | GBX263.92K |
|
Athelney Trust plc
LSE:ATY
|
UK | GBX27.22K |
|
S&W Seed Company
NASDAQ:SANW
|
USA | $42.79 Million |
|
Indus Gas Limited
LSE:INDI
|
UK | GBX1.06 Billion |
|
Thruvision Group PLC
LSE:THRU
|
UK | GBX2.14 Million |
|
Phoenix Global Mining Ltd
LSE:PXC
|
UK | GBX6.58 Million |
Liability Composition Analysis (2017–2024)
This chart breaks down Aditxt Inc. 's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ADTX market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.02 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -2.67 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.75 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Aditxt Inc. 's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Aditxt Inc. (2017–2024)
The table below shows the annual total liabilities of Aditxt Inc. from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $23.86 Million | -16.38% |
| 2023-12-31 | $28.53 Million | +416.04% |
| 2022-12-31 | $5.53 Million | -14.72% |
| 2021-12-31 | $6.48 Million | +210.94% |
| 2020-12-31 | $2.09 Million | -29.93% |
| 2019-12-31 | $2.98 Million | +80.08% |
| 2018-12-31 | $1.65 Million | +1846.34% |
| 2017-12-31 | $84.90K | -- |
About Aditxt Inc.
Aditxt, Inc., a commercial-stage company, discovers and develops products in the areas of immune health, precision health, population health, women's health, and neurologic health. The company develops AditxtScore that enable individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a n… Read more